Fixed-ratio Research Articles

Impact of lower limit of normal or fixed ratio on the diagnosis of chronic obstructive pulmonary disease

慢性阻塞性肺疾病（慢阻肺）是一种可以预防和治疗的呼吸系统疾病。近年来研究结果显示，采用一秒率<正常值低限与一秒率<固定气流受限两种慢阻肺诊断标准，在疾病危险因素、患病率、人口学特征、与临床症状相关性、预后等方面均存在一定差异。本文就此两种诊断标准对慢阻肺诊断及预后进行综述。.

An experimental analysis of the extinction-induced response burst.

The occurrence, time course, and repeatability of response rate increases following the onset of extinction, the extinction burst, were studied in three experiments. Nine pigeons were exposed to at least 5 cycles of 5-session blocks of conditioning followed by 8-session blocks of extinction. In different experiments, conditioning sessions either were a fixed-ratio (FR) or variable-ratio (VR) schedule, and transitions from the last conditioning session in each cycle to the first extinction session were conducted between or within sessions. A single response rate increase occurred when overall response rates were considered. Restricting analyses to the first minute of extinction sessions sometimes revealed increases in response rates, although this finding was inconsistent. The frequency and magnitude of these increases differed across exposures to extinction both across and within pigeons. Additionally, how responding during extinction was measured (i.e., the level of analysis) influenced whether increases above baseline levels were observed. These results suggest that the extinction burst may be influenced by the manner of transition to extinction and the way in which early extinction responding is measured. Under the best conditions, the extinction burst does not appear to be a ubiquitous effect of extinction.

Effort-related decision making in humanized COMT mice: Effects of Val158Met polymorphisms and possible implications for negative symptoms in humans

Catechol-o-methyltransferase (COMT) is an enzyme that metabolizes catecholamines, and is crucial for clearance of dopamine (DA) in prefrontal cortex. Val158Met polymorphism, which causes a valine (Val) to methionine (Met) substitution at codon 158, is reported to be associated with human psychopathologies in some studies. The Val/Val variant of the enzyme results in higher dopamine metabolism, which results in reduced dopamine transmission. Thus, it is important to investigate the relation between Val158Met polymorphisms using rodent models of psychiatric symptoms, including negative symptoms such as motivational dysfunction. In the present study, humanized COMT transgenic mice with two genotype groups (Val/Val (Val) and Met/Met (Met) homozygotes) and wild-type (WT) mice from the S129 background were tested using a touchscreen effort-based choice paradigm. Mice were trained to choose between delivery of a preferred liquid diet that reinforced panel pressing on various fixed ratio (FR) schedules (high-effort alternative), vs. intake of pellets concurrently available in the chamber (low-effort alternative). Panel pressing requirements were controlled by varying the FR levels (FR1, 2, 4, 8, 16) in ascending and descending sequences across weeks of testing. All mice were able to acquire the initial touchscreen operant training, and there was an inverse relationship between the number of reinforcers delivered by panel pressing and pellet intake across different FR levels. There was a significant group x FR level interaction in the ascending limb, with panel presses in the Val group being significantly lower than the WT group in FR1–8, and lower than Met in FR4. These findings indicate that the humanized Val allele in mice modulates FR/pellet-choice performance, as marked by lower levels of panel pressing in the Val group when the ratio requirement was moderately high. These studies may contribute to the understanding of the role of COMT polymorphisms in negative symptoms such as motivational dysfunctions in schizophrenic patients.

The role of NMDA receptors in rat propofol self-administration

BackgroundPropofol is among the most frequently used anesthetic agents, and it has the potential for abuse. The N-methyl-D-aspartate (NMDA) receptors are key mediators neural plasticity, neuronal development, addiction, and neurodegeneration. In the present study, we explored the role of these receptors in the context of rat propofol self-administration.MethodsSprague-Dawley Rats were trained to self-administer propofol (1.7 mg/kg/infusion) using a fixed-ratio (FR) schedule over the course of 14 sessions (3 h/day). After training, rats were intraperitoneally administered the non-competitive NDMA receptor antagonist MK-801, followed 10 min later by a propofol self-administration session.ResultsAfter training, rats successfully underwent acquisition of propofol self-administration, as evidenced by a significant and stable rise in the number of active nose-pokes resulting in propofol administration relative to the number of control inactive nose-pokes (P < 0.01). As compared to control rats, rats that had been injected with 0.2 mg/kg MK-801 exhibited a significantly greater number of propofol infusions (F (3, 28) = 4.372, P < 0.01), whereas infusions were comparable in the groups administered 0.1 mg/kg and 0.4 mg/kg of this compound. In addition, MK-801 failed to alter the numbers of active (F (3, 28) = 1.353, P > 0.05) or inactive (F (3, 28) = 0.047, P > 0.05) responses in these study groups. Animals administered 0.4 mg/kg MK-801 exhibited significantly fewer infusions than animals administered 0.2 mg/kg MK-801 (P = 0.006, P < 0.01). In contrast, however, animals in the 0.4 mg/kg MK-801 group displayed a significant reduction in the number of active nose-poke responses (F (3, 20) = 20.8673, P < 0.01) and the number of sucrose pellets (F (3, 20) = 23.77, P < 0.01), while their locomotor activity was increased (F (3, 20) = 22.812, P < 0.01).ConclusionThese findings indicate that NMDA receptors may play a role in regulating rat self-administration of propofol.

Consummatory, Feeding Microstructural, and Metabolic Effects Induced by Limiting Access to Either a High-Sucrose or a High-Fat Diet.

Background: Binge eating disorder (BED) is characterized by recurrent binge eating episodes consisting of rapid consumption of excessive amounts of highly palatable, energy-dense food within discrete periods of time. The aim of this study was to test the consummatory, food microstructural, and metabolic effects of a one hour limited access to either a high-sucrose diet (HSD) or a high-fat diet (HFD) in an operant rat model of binge-like eating. Methods: Female rats were subject to a binge-like eating procedure in which a HSD, a HFD, or a standard chow diet were provided in a fixed ratio 1 (FR1) operant schedule of reinforcement. Results: Limiting access to either a HSD or a HFD promoted binge-like eating as compared to the control chow diet. However, binge-like eating of HSD, but not HFD, was based on a true increase in the amount of food consumed, an increased eating rate, and a decrease in the intake of the home-cage standard chow, altogether suggesting an increase in palatability. Moreover, while HSD rats consumed overall less energy than HFD rats, the former were more energy efficient and gained more body weight than the latter. Conclusions: These results provide information on how the quality of food can deeply influence the behavioral and metabolic outcomes of binge-like eating.

The Alpha-1 Adrenergic Receptor Antagonist Prazosin Reduces Binge-Like Eating in Rats.

Background: Binge-eating disorder is a pervasive addiction-like disorder that is defined by excessive and uncontrollable consumption of food within brief periods of time. The aim of the current study was to examine the role of the brain noradrenergic system in binge-like eating through the use of the alpha-1 adrenergic receptor antagonist prazosin. Methods: For this purpose, we employed a limited access model whereby male Wistar rats were allowed to nosepoke for either chow (Chow rats) or a sugary, highly palatable food (Palatable rats) for 1 h/day. The effects of prazosin (0, 0.5, 1 and 2 mg/kg, i.p.) were tested in a fixed ratio 1 (FR1) and progressive ratio (PR) schedule of reinforcement. Results: The results show that prazosin preferentially reduced the responses for palatable food in a FR1 reinforcement schedule; when tested in a PR schedule of reinforcement, prazosin increased breakpoint in both Chow and Palatable rats, but more potently and more efficaciously in the latter. Our results suggest that prazosin treatment preferentially increased the motivational properties of the palatable diet. Conclusions: The current findings provide the characterization of the effects of prazosin on binge-like eating and offer support to the existing literature showing the important role of the noradrenergic system in addiction-like behavior.

Astrocytic equilibrative nucleoside transporter type 1 upregulations in the dorsomedial and dorsolateral striatum distinctly coordinate goal-directed and habitual ethanol-seeking behaviours in mice.

Two distinct dorsal striatum regions, dorsomedial striatum (DMS) and dorsolateral striatum (DLS), are attributed to conditioned goal-directed and habitual reward-seeking behaviours, respectively. Previously, our study shows that the ethanol-sensitive adenosine transporter, equilibrative nucleoside transporter 1 (ENT1), regulates ethanol-drinking behaviours. Although ENT1 is expressed in both neurons and astrocytes, astrocytic ENT1 is thought to regulate adenosine levels in response to ethanol. However, the role of DMS and DLS astrocytic ENT1 in goal-directed and habitual ethanol-seeking is not well known. Here, we identified whether the upregulation of astrocytic ENT1 in the DMS and DLS differentially regulates operant seeking behaviours towards the 10% sucrose (10S); 10% ethanol and 10% sucrose (10E10S); and 10% ethanol (10E) in mice. Using 4days of random interval (RI), mice exhibited habitual seeking for 10S, but goal-directed seeking towards 10E10S. Using the same mice conditioned with 10E10S, we examined 10E-seeking behaviour on a fixed ratio (FR) for 6days and RI for 8days. On the other hand, during FR and the first 4days of RI schedules, mice showed goal-directed seeking for 10E, whereas mice exhibited habitual seeking for 10E during the last 4days of RI schedule. Interestingly, DMS astrocytic ENT1 upregulation promotes shift from habitual to goal-directed reward-seeking behaviours. By contrast, DLS astrocytic ENT1 upregulation showed no effects on behavioural shift. Taken together, our findings demonstrate that DMS astrocytic ENT1 contributes to reward-seeking behaviours.

Cebranopadol reduces cocaine self-administration in male rats: Dose, treatment and safety consideration

As a novel first-in-class potent analgesic acting as an agonist of multiple opioid receptors, cebranopadol showed high efficacy and good tolerability in a broad range of preclinical models and clinical trials related to pain. In the present study, to evaluate the efficacy and safety of cebranopadol as a potential treatment of cocaine dependence, we tested the effects of cebranopadol with single and repeated doses (25, 50, 75, or 100 μg/kg, oral gavage) using rat models of cocaine fixed-ratio (FR) self-administration (SA), cocaine progressive-ratio (PR) SA, and sucrose pellet SA. In single-dosing treatment paradigm, cebranopadol significantly and dose-dependently reduced cocaine SA under FR and PR schedules and suppressed food intake under FR schedule without causing apparent side effects. In repeated-dosing treatment scheme, i.e. daily administration of 25, 50, 75, or 100 μg/kg cebranopadol for a week, the similar reduction in cocaine intake was detected, while non-negligible complications/side effects were observed at repeated high doses (75 and 100 μg/kg). The observed side effects were similar to the common toxic signs elicited by heroin at high doses, although cebranopadol did not fully substitute heroin's discriminative stimulant effects in our drug discriminative tests. These results demonstrated that the most appropriate oral dose of cebranopadol to balance the efficacy and safety is 50 μg/kg. Collectively, although cebranopadol may serve as a new treatment for cocaine dependence, more consideration, cautiousness, and a clear optimal dose window to dissociate its therapeutic effects from opioid side effects/complications in male and female subjects will be necessary to increase its practical clinical utility.

Effects of ethanol, naltrexone, nicotine and varenicline in an ethanol and nicotine co-use model in Sprague-Dawley rats

BackgroundAs alcohol and nicotine use disorders are entwined, it may be possible to develop a single medication to treat both. We previously developed a model for ethanol (EtOH) and nicotine co-use in female selectively bred alcohol-preferring (P) rats. To model co-use in a genetically diverse population, we adapted the model to outbred Sprague-Dawley rats of both sexes and assessed the effect of drug pretreatments. MethodsIn phase 1, rats were trained in a 2-bottle choice between water and a sweetened or unsweetened EtOH solution in operant chambers. In phase 2, rats were trained in nicotine self-administration under an increasing fixed ratio (FR) schedule with 2 bottles containing water or saccharin-sweetened EtOH also available. In phase 3, rats were pretreated with EtOH (0.5, 1.5 g/kg), naltrexone (0.3 mg/kg), nicotine (0.2, 0.6 mg/kg), varenicline (3.0 mg/kg) or vehicle before the session. ResultsSweetening the EtOH solution was required to obtain pharmacologically relevant levels of consumption in Phase 1, with males showing increased sweetened EtOH preference compared to females. In Phase 2, increasing the FR requirement for nicotine decreased nicotine infusions, but increased EtOH consumption. In Phase 3, EtOH, naltrexone, and nicotine failed to alter EtOH consumption; however, varenicline decreased both EtOH and nicotine intake. ConclusionsThe co-use model was successfully adapted to Sprague-Dawley rats by adding saccharin to the EtOH solution. In contrast to previous results in P rats, varenicline reduced both EtOH and nicotine intake, indicating it may be a useful monotherapy for co-use in a genetically diverse population.

Aversive Effects of the Kappa Opioid Agonist U‐50488 Alone and in Combination with the Cannabinoid Agonist CP 55,940 in Male Rats

Kappa (κ) opioid receptor agonists can produce prominent analgesic and diuretic effects when administered alone and these effects can be enhanced by the co‐administration of cannabinoids such as CP 55,940. The purpose of the present experiment was to determine if cannabinoids can also enhance the aversive effects of kappa agonists, because these effects substantially reduce their clinical utility as analgesics and aquaretics. To study the aversive effects of kappa agonists and their interaction with cannabinoids, nine male Long‐Evans rats were trained to respond for food under a fixed‐ratio (FR) schedule of food presentation and then implanted with intravenous (i.v.) catheters. Following recovery, the subjects were transitioned to a multiple FR, FR schedule. More specifically, in the presence of a single white stimulus light, food was presented under a fixed‐ratio 30 (FR‐30) schedule (non‐infusion component), whereas presence of both this white stimulus light and a green stimulus light, an i.v. infusion was presented on the first response of each FR and food was presented on the thirtieth FR response (infusion component). When responding was consistent in both components, varying infusion doses of U‐50488 (0.032 – 0.18 mg/kg) replaced the baseline saline infusion until one of three criterion was met: 3 days in which the variability of responding did not vary by ± 20% of the mean, 3 days of responding at less than 0.3 responses per sec, or a maximum of 8 days. After the criterion was met for each dose substitution, the subjects returned to the baseline in which saline served as the infusion and responding was similar between components. To study the interaction of CP 55,940 with the effects of U‐50488, single acute injections of a dose of CP 55,940 (0.056 mg/kg) were administered prior to sessions in which a dose of U‐50488 was available in the infusion component. Each dose‐infusion combination was administered until subjects met the criterion. These effects were then compared to sessions in which one of two doses of naltrexone (1, 3.2 mg/kg) was administered prior the same U‐50488 infusion doses. When infusions of U‐50488 replaced saline, low infusion doses (e.g., 0.056 mg/kg/infusion) selectively suppressed responding in the infusion component, while higher infusion doses (e.g., 0.18 mg/kg/infusion) decreased responding in both components as the total dose of U‐50488 for the session increased. Administration of CP 55,940 did not produce a marked enhancement of the suppressive effects of U‐50488 at the dose tested, and surprisingly, neither dose of naltrexone antagonized its suppressive effects. Together, these data demonstrate the aversive effects of U‐50488 alone, the absence of a marked enhancement by at least one cannabinoid agonist, and the surprising absence of antagonism by the opioid receptor antagonist naltrexone.

A paradigm to specifically assess the respective drives for exercise and feeding in a reward-choice test in mice: Influence of adolescent stress

Introduction Anorexia nervosa (AN), mostly observed in female adolescents, is the most fatal mental illness. Its core is a motivational imbalance between exercise and feeding in favour of the former. Although several animal models of AN have been proposed, none of them specifically assesses the motivation for exercise and/or feeding. In keeping with this issue, we recently developed an operant conditioning-based model wherein motivation for each of these two rewards can be examined singly or within a choice setting in mice [1] . By means of this model, we have recently examined whether infant-early adolescent stress (post-weaning social isolation), one precipitating factor in AN, affects in a sex-dependent manner the reinforcing values of either reward [2] . Methods Stressed and control male/female C57Bl/6 N mice were exposed, when 5-weeks old, to a cued-reward motivated instrumental task wherein wheel-running sequences and palatable food pellets, each reward provided singly, were conditioned by nose-poke responses. These responses obeyed fixed ratio (FR) reinforcement schedules for 10 sessions before being tested under a progressive ratio (PR) schedule of reinforcement for one session. Thereafter, mice underwent 10 FR sessions wherein they had the choice between either reward, the last 5 sessions being performed under food restriction conditions. Infant-adolescent stress, which began at postnatal day 22 (first postweaning day), consisted in individual housing, as compared to controls, which were all collectively housed (3/cage). Results Whether wheel-running and palatable food were provided separately or within a choice paradigm, post-weaning isolation-reared males responded to similar extents for each reward when the three other mouse groups displayed increased responding for wheel-running. The negative impact of the early stressor on male nose poke responding for wheel-running, compared to that measured in the other mouse groups, extended to the running performance during each rewarded sequence (i.e. reward consumption). When food-restricted, motivation for food overpassed progressively that for running in all groups, with females reaching higher levels than males. Conclusions Although the stress model that we used did not trigger a sex-dependent imbalance between exercise and feeding drives that would be reminiscent of what is observed in anorectic girls, we believe that the quest for other stress models, possibly combined with genetics, could prove fruitful to model some endophenotypic traits of AN.

Effects of SCH‐23390 and Alpha‐Methyl‐Tyrosine on the Discriminative Stimulus Effects of Mephedrone in Male Rats

The illicit synthetic cathinone mephedrone (4‐methylmethcathinone) often termed a “bath salt” produces discriminative stimulus effects that are similar, but not identical, to those for central nervous system stimulants such as cocaine and methamphetamine. This may be due to its capacity to bind atypically at both dopamine and serotonin transporters compared to those drugs. The purpose of the present study was to further elucidate the mechanism of action underlying mephedrone’s discriminative stimulus effects by administering it with the dopamine type‐1 receptor antagonist SCH‐23390 (n=11) or the catecholamine synthesis inhibitor alpha‐methyl‐tyrosine (alpha‐MT; n=8). Male Long‐Evans rats were trained to discriminate intraperitoneal injections of mephedrone (3.2 mg/kg) from saline under a fixed‐ratio 20 (FR‐20) schedule of food presentation. Mephedrone dose‐effect curves (0.32 – 10 mg/kg) were then established by administering increasing cumulative doses of mephedrone on test days, and comparing those effects with multiple (4–5) injections of saline. The interaction of SCH‐23390 (0.032 – 0.1 mg/kg) and alpha‐MT (200 mg/kg) with mephedrone was examined by administering an acute injection of these drugs prior to increasing cumulative doses of mephedrone. As shown previously by our laboratory, saline administration produced almost exclusively saline‐lever responding while increasing cumulative doses of mephedrone dose‐dependently increased mephedrone‐lever responding. When SCH‐23390 preceded cumulative doses of mephedrone, neither dose alone produced mephedrone‐lever responding and only the larger of the two doses tested (0.1 mg/kg) shifted the mephedrone dose‐effect curve rightward; however, this shift was still less than 2‐fold and produced rate‐decreasing effects when administered alone. Acute administration of alpha‐MT alone also did not produce mephedronelever responding nor decrease rate, and in combination did not produce a marked rightward shift in the mephedrone dose‐effect curve. Taken together, these data indicate that neither SCH‐23390 nor alpha‐MT effectively antagonize the discriminative stimulus effects of mephedrone, and the alpha‐MT data in particular suggest that mephedrone’s discriminative stimulus effects do not depend on newly synthesized catecholamines.

Receptor Mechanisms in Nicotinic Enhancement of Opioid Antinociception

The use of prescription opioids for pain management can be limited by their adverse behavioral effects, which usually are not measured in the initial preclinical assessment of established or novel candidate analgesics. Recently, we have developed a protocol for concurrently assessing the antinociceptive effects of drugs (an indicator of analgesic promise) and their ability to decrease rates of operant behavior (an indicator of unwanted behavioral effects). Under these procedures, nicotine has been shown to augment the antinociceptive, but not the rate‐decreasing, effects of opioid analgesics with an inverse relationship to efficacy at the m‐opioid receptor‐ e.g., nicotine‐induced enhancement of nalbuphine&gt;oxycodone&gt;fentanyl. The present study was designed to further elucidate nicotinic‐opioid interactions by exploring the role of nicotinic receptor efficacy in the nicotinic augmentation of opioid antinociception. Male squirrel monkeys (n=4) lever‐pressed under a fixed ratio (FR) 10 schedule of 20% (v/v) condensed milk reinforcement. A 30‐s timeout (TO) period followed either the completion of the FR 10 or the elapse of 20‐s (limited hold (LH) 20). During the 30‐s TO, the distal portion of the monkey’s tail was immersed in 35, 50, 52, or 55°C water, and the latency to remove the tail was recorded. Dose response functions for tail‐withdrawal latency and decreases in response rate were generated for the high efficacy m‐opioid agonist fentanyl and the low efficacy m‐agonist nalbuphine alone and in the presence of nicotinic agonists reported to have high or intermediate efficacy‐‐epibatidine (0.00056 mg/kg) or varenicline (0.032 mg/kg), respectively. Fentanyl dose‐dependently increased tail‐withdrawal latencies at all water temperatures and, concomitantly, decreased rates of responding. Nalbuphine did not significantly decrease response rate, and increased tail‐withdrawal latencies at 50 and 52°C, but not at 55°C. Neither epibatidine nor varenicline significantly modified the rate decreasing effects of any of the opioids or the antinociceptive effects of fentanyl. However, the antinociceptive potency of nalbuphine was markedly enhanced by epibatidine (up to ~70‐fold) and only slightly increased by varenicline. The present results add to previous findings with nicotine, showing that nicotinic enhancement of opioid antinociception is inversely related to m‐opioid efficacy. They also extend those findings to suggest that such adjuvant effects are more robustly produced by nicotinic full agonists (nicotine, epibatidine) than a partial agonist (varenicline). In conjunction with previous reports, these findings support the idea that nicotinic agonists may be clinically useful as adjuvants for opioid analgesia.Support or Funding InformationDA035857 and Harvard Medical School Livingston Fellowship

The Sigma1 Receptor Antagonist CM304 Potentiates the Antinociceptive but not the Discriminative Stimulus Effects of the Cannabinoid Receptor Agonist THC in Rats

Opioid overdose is one of the leading causes of death in the United States in people under 50 years, which has resulted in a decline in life expectancy in the United States. Thus, there is a need for an alternative to prescription mu‐opioid agonists for pain treatment. Delta (9)‐tetrahydrocannabinol (THC), a cannabinoid (CB) agonist, has been shown to produce antinociceptive effects albeit less effectively than mu‐opioid receptor agonists. Sigma1 receptor (σ1R) antagonists in combination with THC may provide a viable and safe pharmacological alternative to prescription opioids for pain treatment. The present study compared the pharmacological effects of the σ1R antagonist CM304 alone and in combination with THC in Sprague Dawley rats. Hotplate latency was determined at 52°C followed by rectal temperature measurement and the drugs were administered intravenously (i.v.) and in cumulative doses every 5 min. THC dose‐dependently increased maximum possible effects (MPEs) up to 84% which were reversed by 10 mg/kg rimonabant (cannabinoid CB1 receptor antagonist). CM304 alone up to a dose of 10 mg/kg did not produce significant antinociceptive or hypothermic effects, but CM304 (1.0 and 3.2 mg/kg, i.v.) dose‐dependently left‐shifted the dose‐effect functions of the antinociceptive (7.3‐fold at 3.2 mg/kg CM304) and hypothermic effects of THC. In rats discriminating 3.2 mg/kg THC i.p. from vehicle under a fixed ratio (FR) 10 schedule of food delivery, the cannabinoid CB1 receptor agonist CP55,940 fully substituted for THC, whereas CM304 i.p. produced a maximum of 27 % THC‐lever responding at 17.8 mg/kg. CM304, at doses of 32 and 56 mg/kg, decreased response rate to 24 and 9 %, respectively. No dose of BD1063 (σ1R antagonist), rimonabant, SR144528 (cannabinoid CB2 receptor antagonist), morphine (μ‐opioid receptor agonist), or naltrexone (opioid antagonist) produced greater than 30% THC‐lever responding. Pretreatment with rimonabant (1.78 mg/kg) produced a rightward shift in the dose effect curve of THC (4.5‐fold) and CP55940 (4.5‐fold) while pretreatment with CM304, BD1063, SR144528, and naltrexone had no significant effect on the dose effect curve of THC. The present results may support the development of a σ1R antagonist as an adjunct to cannabinoids for treatment of acute pain without enhancing an undesirable side effect of THC.Support or Funding InformationThis work was supported by National Institute on Drug Abuse grants DA23205 and DA48353.

Ad-libitum high fat diet consumption during adolescence and adulthood impacts the intravenous self-administration of cocaine in male Sprague-Dawley rats.

In preclinical populations, binge consumption of a high-fat diet (HFD) initiated during either adolescence or adulthood increases the intravenous self-administration (IVSA) of cocaine, whereas ad lib HFD consumption initiated during adulthood reduces or fails to influence cocaine intake. From this, it appears that binge exposure is a sufficient condition to increase cocaine IVSA and that such effects occur independent of the exposure period. It is not clear, however, if ad lib exposure would be sufficient to affect the IVSA of cocaine if initiated during adolescence, a developmental period associated with high-risk behavior. To investigate this question, the present experiment evaluated the effects of consumption of a HFD given throughout adolescence and adulthood on cocaine IVSA (0.75 mg/kg/infusion). Specifically, male Sprague-Dawley rats were maintained on either a HFD (n = 24) or chow diet (n = 15) beginning on postnatal day (PND) 21 and as adults underwent cocaine IVSA [Fixed Ratio (FR) 1, FR 5, FR 10, FR 20, Progressive Ratio (PR) and cue- and drug + cue-induced responding] from PNDs 77-126. Under all of these conditions, animals maintained on the HFD displayed higher rates of cocaine IVSA than those given access to chow. The present data demonstrate that under these specific conditions long-term exposure during the risk period of adolescence and extended throughout adulthood is capable of impacting the subsequent likelihood of cocaine self-administration and suggest that diet type and the duration of exposure may be important factors influencing the vulnerability to drug intake. (PsycINFO Database Record (c) 2020 APA, all rights reserved).

Assessing physiological dependence and withdrawal potential of mitragynine using schedule-controlled behaviour in rats.

Kratom is proposed to exhibit therapeutic potential as an opium substitute, but little is known about its dependence-producing profile, particularly of its main psychoactive compound, mitragynine (MG). This study examined the dependence-producing effects of MG using operant-scheduled behaviour in rats and investigated the potential therapeutic effect of MG by comparing effects to buprenorphine in morphine-dependent rats using the same schedule-controlled behavioural task. The effects of acutely administered MG and morphine were determined in rats trained to respond under fixed-ratio (FR) 10 schedule of food reinforcement. Next, the rats were administered MG and morphine twice daily for 14 consecutive days to determine if physiological dependence would develop by examining cessation of drug treatment and following antagonist-precipitated withdrawal. The study then examined the effects of MG substitution to suppress naloxone-precipitated morphine withdrawal effects on scheduled responding. Acute doses of MG did not produce dose-related decreases on FR schedules of responding compared to morphine. Unlike morphine, MG-treated rats showed no suppression of response rates following cessation of MG treatment. However, withdrawal effects were evident for MG after precipitation by either naloxone or SR141716A (rimonabant), similar to morphine-treated rats. MG in higher doses (10 and 30mg/kg) attenuated the naloxone-precipitated morphine withdrawal effects while smaller doses of buprenorphine (0.3 and 1.0mg/kg) were necessary to alleviate these effects. The findings suggest that MG does not induce physiological dependence but can alleviate the physical symptoms associated with morphine withdrawal which represent the desired characteristics of novel pharmacotherapeutic interventions for managing opioid use disorder (OUD).

TRANSITIONS FROM RICH-TO-LEAN SCHEDULES INCREASE ATTACK IN A LABORATORY MODEL OF SOCIAL AGGRESSION IN PIGEONS: II. FIXED-INTERVAL SCHEDULES.

Pigeons key pecked under two-component multiple fixed-interval (FI) schedules. Each component provided a different reinforcer magnitude (small or large), signaled by the color of the key light. Attacks toward a live, protected target pigeon were measured. Large- (rich) and small- (lean) reinforcer components alternated irregularly such that four different interval types (transitions) between the size of the immediately preceding reinforcer and the size of the upcoming reinforcer occurred within each session: lean-to-lean, lean-to-rich, rich-to-lean, and rich-torich transitions. The FI for each component was the same within each phase, but was manipulated across phases. For all pigeons, more attack occurred following the presentations of the larger reinforcer (i.e., during rich-to-lean and rich-to-rich transitions). For 2 of the 3 pigeons, this effect was modulated by the size of the upcoming reinforcer; attack following larger reinforcers was elevated when the upcoming reinforcer was small (i.e., during rich-to-lean transitions). This rich-to-lean effect on attack diminished or disappeared as the length of the FI schedule was increased (i.e., control over attack by the upcoming reinforcer size diminished with increases in the inter-reinforcement interval). For all pigeons and at all FIs, however, postreinforcement pauses were longest during the rich-to-lean transitions. These data (1) are consistent with the notion that postreinforcement periods during intermittent schedules function aversively and, thus, can precipitate aggressive behavior, and (2) suggest that rich-to-lean conditions may be especially aversive. They also indicate, however, that aversive effects of rich-to-lean transitions may differ across fixed-ratio (FR) and FI schedules, and that variables controlling attacking and pausing may not be isomorphic between these different schedule types.

TRANSITIONS FROM RICH-TO-LEAN SCHEDULES INCREASE ATTACK IN A LABORATORY MODEL OF SOCIAL AGGRESSION IN PIGEONS: I. FIXED-RATIO SCHEDULES

Two pigeons key pecked under a two-component multiple fixed-ratio (FR) FR schedule. Each component provided a different reinforcer magnitude (small or large) thatwhich was signaled by the color of the key light. Large- (rich) and small- (lean) reinforcer components randomly alternated to produce four different types of transitions between the size of the immediately preceding reinforcer and the size of the upcoming reinforcer: lean-to-lean, lean-to-rich, rich-to-lean, and rich-to-rich. During probe sessions, a mirror (which was covered during baseline sessions) was uncovered and attack responses toward the mirror were measured, along with the force of individual mirror attacks. The pigeons paused the longest, and attacked most frequently during the rich-to-lean transitions. The pigeons also exhibited some attacksh during lean-to-lean transitions, and pauses were longer during these transitions than during the lean-to-rich and rich-to-rich transitions. Pauses were short and attack infrequent during these last two transition types. In addition, attacks were more forceful during the rich-to-lean transitions thaen during the other transition types. These data are consistent with the view that rich-to-lean transitions function aversively and, as such, generate behavior patterns, including aggression, commonly produced by other aversive stimuli.

Opening the cocaine economy by providing within-session access to a cheaper source of cocaine makes demand for it more elastic.

Previous studies found that opening the cocaine economy by providing postsession access to cocaine had no effect on animals' demand for cocaine, whereas postsession access to saccharin or food made demand for these nondrug reinforcers more elastic. It is possible that there was no effect of economy type on cocaine taking in these earlier studies because of the delay to the postsession cocaine in the open economy. The present experiment tested whether forming an open economy by providing additional within-session cocaine, rather than postsession cocaine, would make rats' demand for cocaine more elastic. Saccharin was used as a nondrug comparison reinforcer. Three groups of rats pressed one lever for cocaine and one for saccharin on an ascending series of fixed ratio (FR) schedules where the number of responses required per reinforcer increased from 1 to 48 over sessions. In the open cocaine and open saccharin economy groups, rats had occasional access during the session to a third lever where cocaine or saccharin reinforcers, respectively, were always available on an FR-1 schedule. The main finding was that demand for cocaine was more elastic in the open cocaine economy group than in either of the other groups. Demand for saccharin was more elastic in the open saccharin economy group than in the open cocaine economy group. This study shows that cocaine taking is sensitive to economy type when the additional source of cocaine in an open economy is available close in time to when rats work for cocaine.

A comparison of accumulated and distributed reinforcement periods with children exhibiting escape-maintained problem behavior.

Differential reinforcement is a common treatment for escape-maintained problem behavior in which compliance is reinforced on a fixed-ratio (FR) 1 schedule with brief access to positive and/or negative reinforcement. Recent research suggests some individuals prefer to complete longer work requirements culminating in prolonged (i.e. accumulated) reinforcement periods relative to brief (i.e. distributed) periods, but prolonged work exposure may evoke problem behavior and prevent compliance from contacting reinforcement when treating escape-maintained problem behavior. We exposed 3 children with escape-maintained problem behavior to both distributed (FR 1 resulting in 30 s of reinforcement) and accumulated (FR 15 resulting in 7.5 min of reinforcement) arrangements to compare their efficacy in maintaining low levels of problem behavior. We then assessed participants' preferences for these conditions in a concurrent-chains arrangement. Accumulated-reinforcement arrangements did not occasion additional problem behavior, but rather resulted in consistently lower levels of problem behavior for 2 of 3 participants. Participants demonstrated idiosyncratic preferences.